awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q41001462-6E0BDEA8-79C6-4F7A-8514-7902C6CA1FA3
Q41001462-6E0BDEA8-79C6-4F7A-8514-7902C6CA1FA3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41001462-6E0BDEA8-79C6-4F7A-8514-7902C6CA1FA3
A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma.
P2860
Q41001462-6E0BDEA8-79C6-4F7A-8514-7902C6CA1FA3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41001462-6E0BDEA8-79C6-4F7A-8514-7902C6CA1FA3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8b27a84835956c3ae760f075d79536a38dbc0247
P2860
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation.